![Partner logo](https://res.cloudinary.com/bizzaboprod/image/upload/q_auto:best,c_crop,g_custom/v1611693453/emrrltrgv6j5eei0n9lp.png)
How private and public organisations can work together to improve access
As global demand for healthcare rises and new treatments come to market, pressure is intensifying on how and what services are delivered. Cancer care is a prime example, with the overall volume of patients growing due to aging populations, and many health systems struggling to deliver increasingly advanced therapies with limited resources. The dual challenge is to make progress on prevention while providing access to the right treatments in a way that is efficient and affordable.
Closer collaboration between industry and healthcare providers has the potential to improve both cancer prevention and access to treatment. What more can be done to support prevention? How can public-private partnerships lead to better cancer care? What role does each stakeholder in the healthcare ecosystem have to play? What are some good examples? Should employers and private sector stakeholders play a bigger role in supporting those with cancer?
Join the Financial Times in partnership with MSD to explore how stakeholders across the healthcare and life sciences sector are working to improve cancer prevention, care and outcomes. Expert speakers will share insights into the solutions and approaches being explored and implemented within health systems in the Middle East, mainly focusing on GCC, Egypt and the Levant.
World-Class Business Leaders and Speakers
![image placeholder](https://cdn-static.bizzabo.com/webattendee/27624/images/home/empty_placeholder.png)
Industry Experts Will Explore
Public - Private Partnerships (PPPs)
What are the key considerations when designing PPPs for the healthcare sector and specifically for cancer? How attractive is it to private sector investors? What are the key measures of success in terms of prevention and progressing access to care?
Cancer Prevention and Access to Care
How can employers play a role in disease and treatment awareness among their employees, supporting prevention, screening and cancer care? Can multinationals work as a catalyst for health equity among their employees? What incentive is there for employers to do so?
Work Culture for Employees with Cancer
What progress is already being made towards building a more open and supportive culture at work for employees with cancer? What are some successful examples of private employers putting cancer prevention promises into action?
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice